PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-111.83%
Both yoy net incomes decline, with CRK at -91.45%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
-280.95%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
120.00%
Well above CRK's 100.00% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-169.12%
Both yoy AR lines negative, with CRK at -2785.87%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
337.21%
Growth well above CRK's 100.00%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
127.13%
Lower 'other non-cash' growth vs. CRK's 1048.64%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-0.20%
Negative yoy CFO while CRK is 172.03%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
4.85%
Some CapEx rise while CRK is negative at -22.08%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-736.36%
Both yoy lines negative, with CRK at -148.97%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-4.46%
Both yoy lines negative, with CRK at -40.34%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-100.94%
Both yoy lines negative, with CRK at -100.00%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
100.00%
We have some buyback growth while CRK is negative at -100.00%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.